Corteva, Inc. research snapshot
CTVA AI stock analysis currently reads Corteva, Inc. as a high-quality agriculture technology company with valuable seed genetics, crop protection products, healthy operating earnings, and a pending October 1, 2026 separation into Vylor (advanced seed and genetics) and New Corteva (crop protection). The analysis is not a certain price prediction. At the August 2, 2026 cutoff, the latest verified close used here was $78.71 on July 31, 2026, market capitalization was about $52.51 billion, and the stock had just fallen about 12% after Q2 2026 earnings that beat operating EPS but missed revenue consensus. The central question is whether the selloff is a healthy reset after a strong run or the start of a re-rating given crop protection pricing pressure in Latin America, PFAS-related litigation, and separation complexity. This is informational research and not investment advice.
Current price
$78.71
Market cap
$52.51 billion
AI score
70 / 100
Rating
Quality agriculture franchise, post-earnings volatility and separation complexity
Trend status
Short-term trend below the 50-day average, longer trend above the 200-day
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | Corteva sells seed genetics, traits, crop protection chemicals, biologicals, and digital agronomy tools into recurring planting and crop care decisions. | High |
| Moat | The moat comes from Pioneer brand equity, germplasm, trait libraries, regulatory approvals, farmer relationships, distribution reach, scale, and R&D depth. | Medium-high |
| Management | Management raised FY2026 operating EPS and EBITDA guidance after a strong first half and is executing the October 1 Vylor spin-off. Execution and post-split capital structures remain open questions. | Medium |
| Financial trend | 1H 2026 net sales rose 4% to $11.28 billion, operating EBITDA rose 10% to $3.70 billion, and operating EPS rose 14% to $3.80, leading to raised full-year guidance. | High |
| Valuation | At $78.71, the stock traded near 48.9x trailing GAAP EPS, 19.91x forward EPS, 2.95x sales, 13.49x EV/EBITDA, and about 21x the midpoint of raised 2026 operating EPS guidance. | Medium |
| Technical trend | CTVA closed below its 50-day moving average with RSI near 35 after the post-earnings drop, while staying above its 200-day moving average. Short-term momentum is weak. | Medium-high |
| Risk level | Key risks are crop commodity pressure, farmer margins, Latin America price competition, PFAS and other litigation, pesticide regulation, weather, FX, and separation costs. | Medium-high |
| AI confidence | High confidence for historical financials, market cap math, share count, and technical levels. Lower confidence for post-separation valuation and the July 31 price reaction. | High data confidence |
| Investment certainty | Medium certainty. Corteva is a strong franchise with raised guidance, but the recent price action shows the market is focused on the revenue miss, crop protection pricing, and separation mechanics. | Medium |
CTVA AI stock forecast
The CTVA AI stock forecast uses scenario ranges around the $78.71 cutoff price. It does not claim that AI can predict a specific future price. The bullish case requires clean separation execution on October 1, resilient seed pricing, recovery in crop protection margins, and a valuation based on forward operating earnings. The base case assumes operating EPS near the raised $3.60 to $3.80 guidance and a moderate forward multiple. The bearish case assumes farm income pressure, regulatory or legal costs, persistent Latin America price pressure, or a messy separation.
$100 to $122
More likely if operating EPS compounds toward $4 or higher, the Vylor spin-off unlocks value, seed technology keeps pricing power, crop protection margins recover, and investors assign a high-teens to low-20s forward earnings multiple.
$80 to $95
More likely if operating EPS lands near the raised $3.60 to $3.80 range, the separation stays on schedule, and CTVA is valued near a 20x forward operating multiple.
$56 to $70
More likely if farm economics weaken, Latin America price pressure persists, legal or regulatory costs rise, or the forward multiple compresses toward mid-teens after the recent breakdown.
CTVA AI technical analysis
CTVA AI technical analysis starts from the $78.71 close on July 31, 2026 used for this August 2 static page. After Q2 earnings, the stock broke below its 50-day moving average and RSI dropped to about 35, while remaining above the 200-day moving average. Because this page does not fetch request-time market data, traders should confirm levels on a live chart before acting.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $78.71 | Latest verified market close used for this page as of the August 2, 2026 data cutoff, from July 31, 2026. |
| Near support | $78.67 to $79 | The July 31 intraday low and recent pivot zone. Holding it would signal the post-earnings selling is contained short term. |
| Secondary support | $75.22 | StockAnalysis showed the 200-day moving average near $75.22, making this the key long-trend reference. |
| Deeper support | $70 to $72 | A zone below the 200-day moving average where a sustained break would open the way toward the 52-week low of $60.54. |
| Near resistance | $82.00 | The 50-day moving average. Reclaiming it on volume would help stabilize the short-term trend after the drop. |
| Next resistance | $84.14 to $86.50 | The July 31 high and the pre-earnings support zone. This area is now the first overhead supply zone. |
| Resistance zone | $89 to $91 | The prior highs and the 52-week high near $90.97. A full recovery would require clearing this area. |
| Momentum | RSI 35.18 | RSI is weak and approaching oversold after the earnings drop, so momentum needs to recover before a trend-following setup is valid. |
| Volume | 20-day average volume about 3.77 million shares | The July 31 selloff printed about 11.5 million shares, well above average and consistent with distribution. Recovery needs volume confirmation. |
| Invalidation | Close below $75.22, then $70 | A close below the 200-day area challenges the long trend. A break below $70 would signal wider technical deterioration. |
CTVA AI trading strategy
The CTVA AI trading strategy is a rules-based framework, not personalized advice. It combines filing-backed fundamentals, separation milestones, trend confirmation, position sizing, and clear invalidation levels.
Wait for CTVA to reclaim the $82.00 50-day area with above-average volume after the post-earnings drop before treating momentum as confirmed.
A failed reclaim or a daily close below the $75.22 200-day area should reduce confidence in the setup.
If CTVA holds the $75.22 to $79 area while the raised FY2026 guidance and October 1 separation milestones remain intact, compare the entry with forward operating EPS, FCF yield, and farm input demand.
Do not average down only because the business has strong technology. Define maximum loss and re-check crop cycle, litigation, and separation risk first.
Track Q3 results, operating EPS guidance, seed pricing, crop protection volume, Latin America price trends, Form 10 effectiveness, the September 15 investor day, and Vylor spin-off mechanics on October 1.
Lower the rating if forward operating EPS guidance weakens while the stock still trades at a premium to its forward multiple.
Investment research summary
Corteva helps farmers raise and protect crop yields through seed genetics, traits, crop protection chemistry, biologicals, and agronomy data.
The moat is built on Pioneer seed brand trust, proprietary germplasm, traits, product registrations, farmer relationships, distribution, and global R&D scale.
The thesis can fail if farm economics deteriorate, Latin America crop protection pricing stays weak, PFAS litigation or pesticide regulation costs rise, weather disrupts, or the separation destroys focus instead of unlocking value.
Management raised FY2026 operating EPS and EBITDA guidance after a strong first half and is executing the October 1 Vylor spin-off. Execution risk remains high until separation is complete.
Food demand, yield pressure, biologicals, gene editing, and climate stress support long-term ag technology demand, but grower spending is cyclical and tied to crop prices.
At $78.71, CTVA trades near 20x forward operating EPS and about 13.5x EV/EBITDA. Margin of safety depends on clean separation, steady operating EPS growth, and avoiding legal or regulatory surprises.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| CTVA price | $78.71 close on July 31, 2026, after a -11.90% move | Market price snapshot and StockAnalysis quote context | August 2, 2026 |
| Market capitalization | $52.51 billion, verified as $78.71 x 667.20 million shares | financial_rigor.py market cap verification and StockAnalysis statistics | August 2, 2026 |
| Shares outstanding | 667.20 million shares | StockAnalysis statistics, S&P Global Market Intelligence | August 2, 2026 |
| FY2025 net sales | $17.40 billion, up 2.92% year over year | Corteva FY2025 release and StockAnalysis financials | August 2, 2026 |
| FY2025 net income attributable to Corteva | $1.09 billion, up 20.62% year over year | StockAnalysis financials and Fiscal.ai | August 2, 2026 |
| Q2 2026 net sales | $6.379 billion, down 1%; organic down 2% | Corteva Q2 2026 earnings release | August 2, 2026 |
| Q2 2026 operating EPS | $2.30, up 5%; GAAP EPS $1.81, down 10% | Corteva Q2 2026 earnings release | August 2, 2026 |
| 1H 2026 operating results | Net sales $11.28 billion up 4%, operating EBITDA $3.70 billion up 10%, operating EPS $3.80 up 14% | Corteva Q2 2026 earnings release | August 2, 2026 |
| FY2026 guidance | Raised to operating EPS $3.60 to $3.80 and operating EBITDA $4.1 to $4.3 billion | Corteva Q2 2026 earnings release | August 2, 2026 |
| Cash and debt | $2.37 billion cash and investments and $4.88 billion total debt at June 30, 2026 | StockAnalysis statistics, S&P Global Market Intelligence | August 2, 2026 |
| Segment mix | 1H 2026 Seed net sales $7.56B; Crop Protection net sales $3.73B | Corteva Q2 2026 earnings release | August 2, 2026 |
| Planned separation | Corteva is on track to complete the planned separation on October 1, 2026, with Vylor (advanced seed and genetics) and New Corteva (crop protection) | Corteva Q2 2026 earnings release and June 2026 board announcements | August 2, 2026 |
| Moving averages and momentum | 50-day MA $82.00, 200-day MA $75.22, RSI 35.18 | StockAnalysis technical snapshot, S&P Global Market Intelligence | August 2, 2026 |
| Valuation math | 48.90x trailing PE, 19.91x forward PE, 2.95x sales, 2.09x book, 13.49x EV/EBITDA | financial_rigor.py valuation verification and StockAnalysis statistics | August 2, 2026 |
| Analyst consensus | Buy rating from 21 analysts, average price target $92.15, range $77 to $103 | S&P Global Market Intelligence via StockAnalysis forecast | August 2, 2026 |
This CTVA AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of August 2, 2026 and can be wrong.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
